Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
13,878 total articles
BridgeBio's recent clinical readouts and a $1 billion preferred equity infusion materially de-risk the company's near-term cash runway while multiple NDA submissions and Attruby's strong long-term mortality signal justify a
Evercore's upgrade to outperform and a cleaner balance sheet give Occidental (OXY) a credible path to re-rating. Free cash flow, modest leverage and strong EV/EBITDA metrics argue for further analyst upgrades and short-covering. This is a tactical long trade for the mid term (45 trading days) with clear risk controls.
Cybin (HELP) is a clinical-stage psychedelic drug developer trading at $6.86 with a $425M market cap. Technical momentum, a shrinking 52-week range, and concentrated short interest create a favorable asymmetric setup ahead of upcoming clinical catalysts. This trade idea targets a mid-term swing (45 trading days) long entry on a pullback, with clear…
SEI Investments (SEIC) is trading at $95.45 with a 15.6x P/E, strong profitability (ROE ~30%), low leverage (debt/equity 0.07) and $634M in free cash flow. Technicals show momentum above the 10/20/50-day averages and short interest is modest. If flows tied to small-cap index rebalancing materialize, SEIC is well positioned to catch a squeeze. This …
Argan (AGX) is a niche engineering and construction play benefiting from a surge in data-center and grid-related power work. With a $2.9 billion backlog, robust free cash flow, and zero net debt, the company has visibility into 2026-2027 revenue and margin expansion. The technical pullback creates an actionable entry with a tight stop-loss and a co…
Frontline's tanker franchise is cashing in on tighter tonnage and geopolitical uncertainty. With a $1.55 quarterly distribution already paid and P/E under 10, the stock offers an attractive risk/reward headed into the summer trading window. We keep a Strong Buy and lay out an explicit entry, stop and target for a mid-term swing trade.
AppFolio is turning AI from a feature into a competitive moat. With recent integrations (Anthropic/Claude, Realm-X modules) and management's track record of converting product innovation into revenue, APPF looks set to re-accelerate growth and expand margins. This trade idea lays out a long entry at $176.00, a $230.00 target over 180 trading days, …
QIAGEN ($QGEN) looks set for a tactical rebound. Industry reports highlighting robust growth in molecular reagents, automated liquid handling and environmental DNA align with the company nd its recent positioning in automation markets. Technical momentum and a compressed valuation vs. recent peak create a favorable risk/reward for a mid-term long t…
BYD (BYDDF) is showing clear momentum in exports and global market reach, but elevated short interest, volatile short-volume flows, and policy/cash-flow uncertainty make the stock vulnerable. We lay out a mid-term short idea with exact entry, stop and target, explain the macro and technical context, and flag the catalysts that could either accelera…
Lumen has moved from value-trap to reshaped telecom play focused on AI-ready fiber and Network as a Service. Balance sheet stress and past revenue erosion are real, but the company is cheap on sales and showing cash generation. Enter a defined long with a tight stop and a 180 trading day horizon to let strategic wins materialize.
Wabash National (WNC) looks like a classic cyclical rebound setup: shares are near the upper end of a wide 52-week range after a severe industry slump, trading above the 50-day and 20-day averages with improving technicals and elevated short interest. Fundamentals still show pressure - negative EPS and negative free cash flow - but the market is be…
Lam Research's leadership in wafer fab equipment positions it to win through the AI-driven memory supercycle, but the stock's rapid run and stretched multiples leave little margin for disappointment. Technicals show weakening momentum and growing distribution; fundamentals remain strong but are largely priced in. We downgrade and propose a tactical…
Nasdaq has the ingredients investors want: growing free cash flow, a healthy ROE, and recurring revenue from exchanges and technology products. The stock is trading below its 52-week high despite clear operational tailwinds tied to recent large listings and record Closing Cross volumes. We recommend a tactical long with a mid-term horizon to captur…
HeartFlow is positioned as a premium AI diagnostics name. This trade targets a rebound tied to accelerating commercial adoption, broader payer traction and margin leverage as fixed costs are spread. Entry at $8.50, stop at $6.00, target $14.00; horizon ~180 trading days.
Crescent Energy (CRGY) is trading cheaply relative to the free cash flow it now generates post-Vital integration. With FCF of roughly $374M, a market cap near $3.13B, and an EV/EBITDA under 5, this is a trade that favors capital return and de-risked cash generation. Entry at $9.25, stop at $8.00, target $13.50 over a 180 trading-day horizon.
Arrow Electronics offers a cleaner risk/reward than Avnet right now. With a $10.5B market cap, a P/E near 14.5, improving revenue momentum and an EV/EBITDA of 9.8, Arrow blends value and growth exposure to EV, IoT and enterprise solutions. My trade: enter ARW at current levels, stop under $196, target $225 over the next 45 trading days.
Lightwave Logic is trading well below its 52-week peak but well above last years lows on a wave of commercialization updates and partnership chatter. The Polariton collaboration and market linkage to larger optics players have turned LWLG into a high-volatility, event-driven trade. This plan targets a mid-term swing while acknowledging thin revenu…
SharonAI (SHAZ) is trading off recent highs but has firm, contracted revenue coming in Q3 2026 from a $1.25B five-year Australian deal and a 72MW NVIDIA factory expansion. Those contracts convert capacity into predictable cash flow as the company scales GPU infrastructure. This trade idea buys the pullback with a $75.43 entry, a $95 target and a $6…
Atlanta Braves Holdings (BATRA) is trading near its 52-week high with the mixed-use Battery Atlanta segment increasingly visible as a growth engine. Ahead of Q2 2026 results, I favor a tactical long position: entry $55.00, stop $51.50, target $61.00. The trade banks on rental and retail momentum at The Battery plus stabilizing baseball operations; …
Nano Labs (NA) trades at a sub-$50M market cap with a PE of ~2.1 and PB ~0.43. Recent insider buying, a North America AI infrastructure MoU and fresh hardware launches give catalysts to re-rate. This trade idea sizes NA as a high-risk long with a strict stop below the 52-week low and a 2.3x price target over the next 180 trading days.
El Pollo Loco has posted better-than-expected results and comp trends that contrast with a softer restaurant backdrop. With a modest valuation and low leverage, the stock is a candidate for a mid-term swing trade: enter near $16.65, protect at $15.00, target $18.50 over the next 45 trading days.
Ares Commercial Real Estate (ACRE) trades at about $4.43 with a dividend yield north of 13% and a price-to-book near 0.5. The trade is a long, position-sized idea that leans on a large yield, a market-capitalization cushion versus book value, and improving technical stability. We lay out an entry at $4.43, a conservative target at $5.50 and a stop …
Nvidia remains the central plumbing of the AI era. Recent weakness has translated into a more accessible entry for investors who believe the company’s move from discrete GPUs toward a software-and-platform moat will sustain revenue and cash-flow compounding. This trade targets $260 while limiting downside with a $191 stop, sized for investors who w…
Dollarama is executing a disciplined international expansion that should drive multi-year store growth and margin improvement. The trade here is a long with defined entry at $47.00, a $60.00 target and a $40.00 stop, reflecting conviction in the growth vector while protecting capital against execution or macro shocks.
Paccar's parts division is outperforming the cyclical truck business and should support an earnings recovery and a re-rating. With healthy free cash flow, a conservative balance sheet and technical momentum, a mid-term long trade in PCAR is actionable: entry $124.50, stop $116.00, target $135.00 over ~45 trading days.
